Trial · NCT02299791
Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
NCT02299791, Not applicable, Completed, Kaiser Permanente; results first posted 2017-10-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics. Trials, record NCT02299791. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02299791
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics
- NCT number
- NCT02299791
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 4,856 participants, actual
- Lead sponsor
- Kaiser Permanente
- Conditions
- Diabetes Mellitus, Cardiovascular Diseases
- Interventions
- ALL, ALL
- First posted
- 2014-11-24
- Last updated
- 2017-10-04
- Results first posted
- 2017-10-04
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both | Percent of clinic patients prescribed guideline-concordant cardioprotective medications, as of the 1st day of each month, from up to 36 months | Number of patients indicated for ACE/ARB and statin who had an active prescription for both, as a proportion of patients indicated for ACE/ARB and statin. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both | Percent of clinic patients prescribed guideline-concordant cardioprotective medications, as of the 1st day of each month, from up to 36 months | clinic patients with diabetes who had a clinic encounter (in person or by telephone) within the previous year and were indicated for ACE/ARB and statin per current national care guidelines | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both | Early Intervention | 1279 | Participants | ||
| Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both | Late Implementation | 1318 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Early Intervention Number of Patients | 2,053 | 6 |
| Overall Study | STARTED | Late Interventions Number of Patients | 2,803 | 5 |
| Overall Study | COMPLETED | Early Intervention Number of Patients | 2,053 | 6 |
| Overall Study | COMPLETED | Late Interventions Number of Patients | 2,803 | 5 |
| Overall Study | NOT COMPLETED | Early Intervention Number of Patients | 0 | 0 |
| Overall Study | NOT COMPLETED | Late Interventions Number of Patients | 0 | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Early Intervention | 0 | 0 |
| Total, all-cause mortality | Late Implementation | 0 | 0 |
| Total, other adverse events | Early Intervention | 0 | 0 |
| Total, other adverse events | Late Implementation | 0 | 0 |
| Total, serious adverse events | Early Intervention | 0 | 0 |
| Total, serious adverse events | Late Implementation | 0 | 0 |
Source ClinicalTrials.gov
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R18HL095481 | Dissemination of CVD risk factor treatment among diabetic patients in FQHCs | GOLD, RACHEL | KAISER FOUNDATION RESEARCH INSTITUTE | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE | 2010 to 2014 |
Source NIH RePORTER
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Early Intervention vs Late Implementation: Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02299791
GET https://conductscience.org/api/trials/v1/NCT02299791/registered